Company / Net Debt per Share
Corcept Therapeutics Incorporated Net Debt per Share History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.28
FY2017
5-year range
-
FY2016-FY2017
Trend
-24.6%
vs FY2016
Sector context
#54 of 82
Health Care
What the data says
At $-0.28, Corcept Therapeutics Incorporated's net debt per share ranks #29 of 82 in the Health Care sector.
Based on SEC 10-K filings.
-0.28 in FY2017.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#29 of 82 in Health CareTop 34% of 82This company -$0.28 Sector average $13.62
▼
-102.0% below sector average
Key checks
Key Insights
- In FY2017, net debt per share decreased 24.6% year-over-year.
- Ranks #54 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -$0.28 | -24.6% |
| FY2016 | -$0.22 | +19.6% |
As of FY2017 · SEC 10-K · Updated Jul 4, 2026